API
< Back to all clusters
[HEALTH] · United States · 2 sources

started · updated

Alzheimer’s research explores anti-amyloid drugs and hormonal risk factors

Scientists are investigating new approaches to combat Alzheimer’s disease, focusing on both pharmaceutical interventions and biological risk factors. Research into anti-amyloid drugs, such as lecanemab and donanemab, aims to clear amyloid plaques from the brain. These abnormal protein deposits are believed to drive neuronal damage, and early-stage treatments have shown potential in modestly slowing cognitive decline.

Additional studies presented at the Neuroscience 2026 meeting suggest that menopause and inherited genes may interact to influence Alzheimer’s risk. Research indicates that hormone levels during menopause may affect brain cells differently in individuals with specific genetic predispositions. Findings suggest that menopause hormone therapy may have varying effects depending on a person's genetic risk, highlighting the importance of biological sex and individual biology in brain health and disease progression.

Entities

Society for Neuroscience